BioSpace News Archive

NeuPath Health Inc. (TSXV:NPTH) (“NeuPath” or the “Company”), Canada’s largest provider of chronic pain management services, is pleased to announce that the Company has been invited to participate in the inaugural Desjardins Digital Healthcare Conference, hosted by Desjardins Capital Markets.

Syros Pharmaceuticals (NASDAQ:SYRS), a leader in the development of medicines that control the expression of genes, today announced that it will present initial data from the ongoing dose escalation portion of its Phase 1 clinical trial of SY-5609, its highly selective and potent oral cyclin-dependent kinase 7 (CDK7) inhibitor, in patients with select solid tumors.

Recent Congressional testimony from Robert Redfield, Director of the Centers for Disease Control and Prevention (CDC), stating that surgical masks are more effective at stopping the spread of COVID-19 than a vaccine has once again put mask wearing back in the headlines. Miami-based mask manufacturer DemeTECH has disrupted the PPE (Personal Protective Equipment) industry

The drive for periodontal scalers and curettes market stems from the growing awareness about the problems of plaque and calculus from tooth surfaces and gingival roots.

Exelixis, Inc. announced new data that support the ongoing clinical development of XL092, the company’s next-generation oral tyrosine kinase inhibitor that targets VEGF receptors, MET, AXL, MER, and other kinases implicated in cancer’s growth and spread.

Spine surgeon Christopher Good used augmented reality technology to perform lumbar fusion with new technology that essentially gives surgeons ‘x-ray vision’ during complex procedures.

CNS Pharmaceuticals, Inc. (NASDAQ: CNSP) (“CNS” or the “Company”), today announced that the Company’s European manufacturer, BSP Pharmaceuticals S.p.A. (“BSP”),

Beckman Coulter, a clinical diagnostics leader, today announced its Access SARS-CoV-2 Immunoglobulin M (IgM) assay has received Emergency Use Authorization (EUA) from the U.S. Food and Drug Administration (FDA).

Intersect ENT, Inc. (Nasdaq: XENT), a company transforming care for patients with ear, nose and throat (“ENT”) conditions, today announced that it will release third quarter 2020 financial results on November 2, 2020.

BioReference Laboratories, Inc., an OPKO Health company (NASDAQ :OPK), today announced the beginning of its COVID-19 testing program for New York City schools throughout the 2020-2021 school year to help ensure a safer school environment.